A Randomized Trial of Telemedicine for Migraine Management
- Deborah Freidman, Departments of Neurology and Neurotherapeutics and Ophthalmology, University of Texas Southwestern Medical School, Dallas, Texas, United States
- Balaraman Rajan, California State University East Bay, Hayward, California, United States
- Abraham Seidmann, Simon Business School, University of Rochester, Rochester, New York, United States
AbstractMigraine is the third most common disease worldwide, and most common primary headache disorder for which people seek medical care. Telemedicine offers the capability of increasing access to care by providing expertise in headache medicine to patients in diverse locations and circumstances. We evaluated long term follow-up care using telemedicine over a one-year period in migraine patients with severe headache disability who were evaluated in a headache medicine program at a tertiary referral center. Our study provides evidence that telemedicine is a viable method of conducting follow-up visits for migraine patients having severe migraine-related disability, with no difference in outcome at one year compared to in-office visits. The evidence is clear that despite the lack of ‘personal touch’, participants randomized to telemedicine were highly satisfied with their care. This is probably due to the added convenience afforded by the technology and their experienced efficacy of the telemedicine-care-delivery channel.
Return to previous page